Synexin-like proteins from human polymorphonuclear leukocytes. Identification and characterization of granule-aggregating and membrane-fusing activities.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 2953727)

Published in J Biol Chem on June 05, 1987

Authors

P Meers, J D Ernst, N Düzgünes, K L Hong, J Fedor, I M Goldstein, D Papahadjopoulos

Articles by these authors

Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S A (1978) 6.55

Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest (1975) 6.25

Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. Biochim Biophys Acta (1973) 4.25

Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophys Bioeng (1980) 4.02

Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev (1999) 4.02

Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res (1994) 3.54

Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles. J Exp Med (1971) 3.38

Phospholipid model membranes. I. Structural characteristics of hydrated liquid crystals. Biochim Biophys Acta (1967) 3.29

Calcium-induced lysozyme secretion from human polymorphonuclear leukocytes. Biochem Biophys Res Commun (1974) 3.24

Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta (1979) 3.20

Surface properties of acidic phospholipids: interaction of monolayers and hydrated liquid crystals with uni- and bi-valent metal ions. Biochim Biophys Acta (1968) 3.17

Evidence that the superoxide-generating system of human leukocytes is associated with the cell surface. J Clin Invest (1977) 2.77

Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A (1988) 2.74

Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation. J Immunol (1973) 2.66

Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. Biochim Biophys Acta (1975) 2.62

Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2001) 2.59

Studies on the mechanism of membrane fusion: evidence for an intermembrane Ca2+-phospholipid complex, synergism with Mg2+, and inhibition by spectrin. Biochemistry (1979) 2.46

Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J Immunol (1999) 2.37

Phase transitions and phase separations in phospholipid membranes induced by changes in temperature, pH, and concentration of bivalent cations. Biochemistry (1975) 2.34

Local anesthetics affect transmembrane cytoskeletal control of mobility and distribution of cell surface receptors. Proc Natl Acad Sci U S A (1975) 2.26

Introduction of liposome-encapsulated SV40 DNA into cells. J Biol Chem (1980) 2.23

Potassium and amino acid transport in human leukocytes exposed to phagocytic stimuli. J Cell Biol (1974) 2.16

Studies on membrane fusion. III. The role of calcium-induced phase changes. Biochim Biophys Acta (1977) 2.15

Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta (1991) 2.08

Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev Infect Dis (1984) 2.08

Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res (1996) 2.07

Studies on the mechanism of membrane fusion: kinetics of calcium ion induced fusion of phosphatidylserine vesicles followed by a new assay for mixing of aqueous vesicle contents. Biochemistry (1980) 2.06

Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. J Immunol (1974) 2.02

Independent effects of IgG and complement upon human polymorphonuclear leukocyte function. J Immunol (1976) 1.97

Effects of local anesthetics on membrane properties. I. Changes in the fluidity of phospholipid bilayers. Biochim Biophys Acta (1975) 1.89

Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes. Biochemistry (1985) 1.88

Mechanisms of lysosomal enzyme release from human polymorphonuclear leukocytes. Effects of phorbol myristate acetate. J Cell Biol (1975) 1.87

Studies on the mechanism of action of local anesthetics with phospholipid model membranes. Biochim Biophys Acta (1972) 1.85

Ceruloplasmin. A scavenger of superoxide anion radicals. J Biol Chem (1979) 1.84

Studies on the mechanism of membrane fusion. Role of head-group composition in calcium- and magnesium-induced fusion of mixed phospholipid vesicles. Biochim Biophys Acta (1981) 1.82

Effects of phospholipid acyl chain fluidity, phase transitions, and cholesterol on (Na+ + K+)-stimulated adenosine triphosphatase. J Biol Chem (1974) 1.79

Effects of proteins on thermotropic phase transitions of phospholipid membranes. Biochim Biophys Acta (1975) 1.77

Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunol (2011) 1.77

Membrane fusion and molecular segregation in phospholipid vesicles. Biochim Biophys Acta (1974) 1.73

Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after internalization in coated vesicles. Cell (1983) 1.73

Electron diffraction study of hydrated phospholipid single bilayers. Effects of temperature hydration and surface pressure of the "precursor" monolayer. Biochim Biophys Acta (1975) 1.73

Experimental pneumococcal meningitis: role of leukocytes in pathogenesis. Infect Immun (1983) 1.72

Phospholipid model membranes. II. Permeability properties of hydrated liquid crystals. Biochim Biophys Acta (1967) 1.71

Characterization of Ca2(+)-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem J (1990) 1.71

Lipid vesicles as carriers for introducing biologically active materials into cells. Methods Cell Biol (1976) 1.70

Role of microtubule assembly in lysosomal enzyme secretion from human polymorphonuclear leukocytes. A reevaluation. J Cell Biol (1977) 1.69

Adherence of human polymorphonuclear leukocytes to endothelial monolayers: effects of temperature, divalent cations, and chemotactic factors on the strength of adherence measured with a new centrifugation assay. Blood (1985) 1.69

Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim Biophys Acta (1980) 1.66

Liposomes revisited. Science (1995) 1.66

Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood (1996) 1.64

Fusion of mammalian cells by unilamellar lipid vesicles: inflluence of lipid surface charge, fluidity and cholesterol. Biochim Biophys Acta (1973) 1.63

Sudden blindness in acute pancreatitis. Possible role of complement-induced retinal leukoembolization. Arch Intern Med (1981) 1.62

Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res (1992) 1.62

Calcium/magnesium specificity in membrane fusion: kinetics of aggregation and fusion of phosphatidylserine vesicles and the role of bilayer curvature. Biochemistry (1981) 1.62

Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med (1973) 1.61

Endocytosis and intracellular fate of liposomes using pyranine as a probe. Biochemistry (1990) 1.60

Membrane action of DMSO and other chemical inducers of Friend leukaemic cell differentiation. Nature (1976) 1.59

Thromboxane generation by human peripheral blood polymorphonuclear leukocytes. J Exp Med (1978) 1.57

Biological properties of poliovirus encapsulated in lipid vesicles: antibody resistance and infectivity in virus-resistant cells. Proc Natl Acad Sci U S A (1977) 1.57

Specificity of Ca2+ and Mg2+ binding to phosphatidylserine vesicles and resultant phase changes of bilayer membrane structure. Biochim Biophys Acta (1978) 1.57

Permeability properties of phospholipid membranes: effect of cholesterol and temperature. Biochim Biophys Acta (1972) 1.56

Tumor targeting using anti-her2 immunoliposomes. J Control Release (2001) 1.56

Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am J Respir Cell Mol Biol (1996) 1.52

Studies on membrane fusion. II. Induction of fusion in pure phospholipid membranes by calcium ions and other divalent metals. Biochim Biophys Acta (1976) 1.51

Lipid vesicles as carriers for introducing materials into cultured cells: influence of vesicle lipid composition on mechanism(s) of vesicle incorporation into cells. Proc Natl Acad Sci U S A (1976) 1.48

Effects of local anesthetics on membrane properties. II. Enhancement of the susceptibility of mammalian cells to agglutination by plant lectins. Biochim Biophys Acta (1975) 1.46

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry (1997) 1.45

Immune responses in tuberculosis. Curr Opin Immunol (2000) 1.44

Ca2+-induced fusion of phospholipid vesicles monitored by mixing of aqueous contents. Nature (1979) 1.44

Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. J Biol Chem (1984) 1.44

Enhancement of nitroblue tetrazolium dye reduction by leukocytes exposed to a component of complement in the absence of phagocytosis. J Immunol (1975) 1.43

Influence of divalent cations upon complement-mediated enzyme release from human polymorphonuclear leukocytes. J Immunol (1975) 1.43

Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci (1998) 1.43

Phospholipid requirements for (Na + + K + )-ATPase activity: head-group specificity and fatty acid fluidity. Biochim Biophys Acta (1972) 1.42

An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus. J Clin Invest (1990) 1.41

Gastrointestinal "sterilization" in the treatment of patients with acute leukemia. Cancer (1970) 1.39

Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions. Biochemistry (1981) 1.39

Microvascular studies on the origins of perfusion-limited hypoxia. Br J Cancer Suppl (1996) 1.38

Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res (1992) 1.38

Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis. Antimicrob Agents Chemother (1983) 1.37

Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro. Reduction of lysosomal enzyme release and superoxide anion production. J Exp Med (1977) 1.36

Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother (1987) 1.35

Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett (1997) 1.33

Incorporation of lipid vesicles by mammalian cells provides a potential method for modifying cell behaviour. Nature (1974) 1.33

Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys (1996) 1.32

Role of cholesterol in membranes. Effects on phospholipid-protein interactions, membrane permeability and enzymatic activity. Biochim Biophys Acta (1973) 1.32

Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting. J Biol Chem (1982) 1.32

Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg. J Immunol (1985) 1.30

Incorporation of macromolecules within large unilamellar vesicles (LUV). Ann N Y Acad Sci (1978) 1.28

A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus. J Clin Invest (1978) 1.28

Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. Am Rev Respir Dis (1984) 1.28

Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds. Biochemistry (1981) 1.27

Specificity of Na+ binding to phosphatidylserine vesicles from a 23Na NMR relaxation rate study. Biochim Biophys Acta (1979) 1.27

Molecular basis for a polymorphism involving Fc receptor II on human monocytes. J Immunol (1989) 1.27

A single amino acid distinguishes the high-responder from the low-responder form of Fc receptor II on human monocytes. Eur J Immunol (1991) 1.26

Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes. Biochemistry (1993) 1.26

Interactions of basic proteins with phospholipid membranes. Binding and changes in the sodium permeability of phosphatidylserine vesicles. J Biol Chem (1971) 1.25

The (alpha2-->8)-linked polysialic acid capsule of group B Neisseria meningitidis modifies multiple steps during interaction with human macrophages. Infect Immun (1996) 1.25

Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim Biophys Acta (1996) 1.25